Study Of Celecoxib Or Diclofenac For Efficacy and Safety In Chinese Patients With Ankylosing Spondylitis
Clinical trial NCT00762463 · COMPLETED
Trial details
- NCT number
- NCT00762463
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2010-06-01
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.